The Antihypertensive Effects and Safety of LCZ696 in Patients with Hypertension: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

The Antihypertensive Effects and Safety of LCZ696 in Patients with Hypertension: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

Background: The management of hypertension remains suboptimal throughout the world. Methods: We performed a random-effects model meta-analysis of randomized controlled trials to determine the effectiveness and safety of sacubitril/valsartan (LCZ696) for the treatment of high arterial pressure. Relev...

Full description

Bibliographic Details
Main Authors:	Su-Kiat Chua, Wei-Ting Lai, Lung-Ching Chen, Huei-Fong Hung
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Journal of Clinical Medicine
Subjects:	LCZ696 ambulatory systolic blood pressure hypertension
Online Access:	https://www.mdpi.com/2077-0383/10/13/2824

Similar Items

The protective effect of LCZ696 in coxsackievirus B3‐induced acute viral myocarditis mice
by: Xu Jing, et al.
Published: (2023-02-01)

LCZ696 mitigates diabetic-induced nephropathy through inhibiting oxidative stress, NF-κB mediated inflammation and glomerulosclerosis in rats
by: Mohamed Mohany, et al.
Published: (2020-06-01)

Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
by: Xiao Juan Liu, et al.
Published: (2020-10-01)

LCZ696 Protects against Diabetic Cardiomyopathy-Induced Myocardial Inflammation, ER Stress, and Apoptosis through Inhibiting AGEs/NF-κB and PERK/CHOP Signaling Pathways
by: Osamah M. Belali, et al.
Published: (2022-01-01)

Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
by: Aleksandra M. Sobiborowicz-Sadowska, et al.
Published: (2023-01-01)

The Role of NF-κB and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease
by: Mohamed Mohany, et al.
Published: (2022-11-01)

Efficacy and safety of sacubitril/valsartan in heart failure compared to renin–angiotensin–aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials
by: Adrian V. Hernandez, et al.
Published: (2023-05-01)

Remote versus face-to-face ambulatory blood pressure monitoring: de-identified blood pressure data from 65 participants of the Screening for Hypertension in the Inpatient Environment (SHINE) study
by: Armitage, L, et al.
Published: (2021)

Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials
by: Wanqian Yu, et al.
Published: (2022-09-01)

Chikungunya
by: C. Roxanne Rutledge-Connelly, et al.
Published: (2007-04-01)

Peculiarities of 24 hour ambulatory blood pressure monitoring indices in patients with essential hypertension, stage II of different age groups
by: V. S. Pasko
Published: (2018-09-01)

Healthy Eating for Elders: Drink to Your Health
by: Jennifer Hillan
Published: (2004-08-01)

Nutrition for Health and Fitness: Sodium in Your Diet
by: Linda B. Bobroff
Published: (2010-10-01)

Healthy Eating: Drink to Your Health
by: Jennifer Hillan, et al.
Published: (2012-04-01)

Healthy Eating: Drink to Your Health
by: Jennifer Hillan, et al.
Published: (2015-11-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN AND RAMIPRILIN ELDERLY PATIENTS WITH MILD TO MODERATE SYSTOLIC AND DIASTOLICESSENTIAL HYPERTENSION
by: J‑M. Mallion, et al.
Published: (2012-06-01)

THE EFFICACY OF ANTIHYPERTENSIVE TREATMENT COMBINATION WITH ANXIOLYTICS IN HYPERTENSIVES WITH ANXIETY DISORDER
by: D. V. Kovalev, et al.
Published: (2017-05-01)

COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION
by: Yu. I. Grinshtein, et al.
Published: (2016-01-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY
by: E. Malacco, et al.
Published: (2012-02-01)

Evaluation on Conventional Antihypertension Use and Natural-Conventional Combination on Patient with Hypertension
by: Sefni Gusmira
Published: (2013-06-01)

Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction
by: Luis Ortega‐Paz, et al.
Published: (2023-02-01)

Some features of blood pressure variability in patients with arterial hypertension in various modes of antihypertensive therapy
by: O. V. Kanishcheva, et al.
Published: (2020-07-01)

Systolic Blood Pressure and Pulse Pressure Are Predictors of Future Cardiovascular Events in Patients with True Resistant Hypertension
by: J. Mesquita Bastos, et al.
Published: (2023-05-01)

AMBULATORY BLOOD PRESSURE MONITORING INDICATORS IN MIDDLE-AGED AND ELDERLY HYPERTENSIVE PATIENTS UNDER COMBINED ANTIHYPERTENSIVE THERAPY
by: V.S. Pasko
Published: (2021-10-01)

Penalized Model‐Based Unsupervised Phenomapping Unravels Distinctive HFrEF Phenotypes With Improved Outcomes Discrimination From Sacubitril/Valsartan Treatment Independent of MAGGIC Score
by: Kuo‐Tzu Sung, et al.
Published: (2023-09-01)

Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study
by: Anne C. K. Larstorp, et al.
Published: (2019-09-01)

Prevalence of Undiagnosed Hypertension and Its Predictors in Jordan: A Cross-Sectional Study
by: Alhawari H, et al.
Published: (2022-10-01)

Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials
by: Mattias Brunström, et al.
Published: (2023-12-01)

Quantification urban heat island (UHI) using the local climate zone classification (LCZ): A case study in Constantine
by: Dounia KHELLAF, et al.
Published: (2022-08-01)

Quantification urban heat island (UHI) using the local climate zone classification (LCZ): A case study in Constantine
by: Dounia KHELLAF, et al.
Published: (2022-08-01)

Quantification urban heat island (UHI) using the local climate zone classification (LCZ): A case study in Constantine
by: Dounia KHELLAF, et al.
Published: (2022-08-01)

Quantification urban heat island (UHI) using the local climate zone classification (LCZ): A case study in Constantine
by: Dounia KHELLAF, et al.
Published: (2022-08-01)

PECULIARITIES OF 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING INDICES IN HYPERTENSIVE PATIENTS OF DIFFERENT AGE GROUPS
by: V.S. Pasko
Published: (2022-09-01)

Coexistence of hypertension and other variables in oral and maxillofacial clinic
by: Arthur N
Published: (2019-08-01)

LCZ696 (sacubitril/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4
by: Mengjia Shen, et al.
Published: (2023-06-01)

The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population
by: Giuseppe Dattilo, et al.
Published: (2023-09-01)

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY
by: O. A. Osipova, et al.
Published: (2016-01-01)

THE EFFICACY OF ANTIHYPERTENSIVE THERAPY IN ELDERLY PATIENTS AND TREATMENT COMPLIANCE ANALYSIS
by: V. E. Olejnikov, et al.
Published: (2015-09-01)

Modeling of Daytime and Nighttime Surface Urban Heat Island Distribution Combined with LCZ in Beijing, China
by: Yinuo Xu, et al.
Published: (2022-11-01)

Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach
by: Fabio Angeli, et al.
Published: (2023-04-01)